Urinary estrogen metabolites and prostate cancer risk: a pilot study. - Wikidata - awgldk - TriplyDB

Urinary estrogen metabolites and prostate cancer risk: a pilot study.

Urinary estrogen metabolites and prostate cancer risk: a pilot study.

http://www.wikidata.org/entity/Q34567583

about

Metabolomics for tumor marker discovery and identification based on chromatography-mass spectrometry.Bringing GC-MS profiling of steroids into clinical applications.Smoking and prostate cancer: a life course analysis.

P2860

Q38103592-4A3BBCB3-8903-4555-AFC6-0D4DF3B9F279 Q38223309-8C88EB8B-0855-41FA-9FCA-A5FDBAB4E8CC Q48507823-488E4618-FCF8-410E-84D8-9749BD8D63EB

P2860

Urinary estrogen metabolites and prostate cancer risk: a pilot study.

http://www.wikidata.org/entity/Q34567583

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Urinary estrogen metabolites and prostate cancer risk: a pilot study.

@ast

Urinary estrogen metabolites and prostate cancer risk: a pilot study.

@en

Urinary estrogen metabolites and prostate cancer risk: a pilot study.

@nl

type

label

Urinary estrogen metabolites and prostate cancer risk: a pilot study.

@ast

Urinary estrogen metabolites and prostate cancer risk: a pilot study.

@en

Urinary estrogen metabolites and prostate cancer risk: a pilot study.

@nl

prefLabel

Urinary estrogen metabolites and prostate cancer risk: a pilot study.

@ast

Urinary estrogen metabolites and prostate cancer risk: a pilot study.

@en

Urinary estrogen metabolites and prostate cancer risk: a pilot study.

@nl

P1433

Q34567583-1E48A48D-F6E5-42E5-90C8-2278CC7716E9

P1476

Q34567583-FA1E4802-34F6-416A-967B-06C5E06D7CC9

P2093

Q34567583-099FACD5-8CCC-41D1-A037-2BC7DC70B47C

Q34567583-121772B8-CF2B-496C-9717-94A8673C942D

Q34567583-3FBA33B4-FEED-44F0-99D2-9520EAC152D0

Q34567583-46B91C79-1326-40D1-96F3-24F2C7CE8BB9

Q34567583-52635F21-B490-46B2-9173-64FB5BBD241A

Q34567583-57659ECE-E1CF-4AE8-8F4C-5327B2B8BBAA

Q34567583-66E95C3B-8502-48CE-B2BC-0544CDA30C57

Q34567583-8F5DEC6B-2B70-428C-BBFE-15A4A452A006

Q34567583-9317769C-9EEB-4FCB-A049-7429EF31B55D

Q34567583-A361C63A-B8BC-4FB0-8280-4ECD8D677D02

P2860

Q34567583-0A480040-2E9B-483C-9191-37D2DA322A4F

Q34567583-0A7D31A6-63D3-49D6-AADB-0961C8911E46

Q34567583-11773E80-2FCA-4F4A-93CC-FD8F5CEEC7DF

Q34567583-1689E5C5-A4B9-437C-A658-A0EC8978B0CD

Q34567583-1D78FD5A-9A26-46D1-A12A-39BE33CF5AAF

Q34567583-2B74A020-3FA2-4839-9287-FEA8DD744A12

Q34567583-31E934FE-7674-4ABC-8F16-385CDD08F72C

Q34567583-334CD3E6-6D70-40A7-9616-BCB8FE2BAA56

Q34567583-3959FBAA-32F9-4081-8FC2-97D8E93A2984

Q34567583-3CEA8595-C24F-42F0-B60D-F0B7927C0F74

P304

Q34567583-2884E3CF-D2FD-442D-A604-527B54709CBE

P31

Q34567583-EF60AE7D-D3DC-4285-8083-51DEA69AC4C8

P356

Q34567583-715B0ABA-73C6-417D-A0E7-7ACC1A8C75C8

P433

Q34567583-3AD11F61-EC0B-4924-9C81-036DA559412E

P478

Q34567583-251C4E62-6415-4471-87A8-265AD2954E49

P577

Q34567583-1656C1D8-3F94-4B7A-B575-F6169224C608

P5875

Q34567583-64D67799-FC4C-44E7-958C-3BAD2B114C31

P698

Q34567583-A369A5CA-DC21-4113-8CF6-AE82A1455943

P932

Q34567583-FF93899C-33FD-4E55-8039-88AD5BADF6B5

P356

P1433

P1476

Urinary estrogen metabolites and prostate cancer risk: a pilot study.

@en

P2093

Anatoly Dritschilo

http://www.w3.org/2001/XMLSchema#string

Ann W Hsing

http://www.w3.org/2001/XMLSchema#string

Ionut Bebu

http://www.w3.org/2001/XMLSchema#string

John H Lynch

http://www.w3.org/2001/XMLSchema#string

Lenka Goldman

http://www.w3.org/2001/XMLSchema#string

Lisa W Chu

http://www.w3.org/2001/XMLSchema#string

Ourania Kosti

http://www.w3.org/2001/XMLSchema#string

Radoslav Goldman

http://www.w3.org/2001/XMLSchema#string

Sean Collins

http://www.w3.org/2001/XMLSchema#string

Timothy D Veenstra

http://www.w3.org/2001/XMLSchema#string

P2860

The development of prostatic adenocarcinoma in Nb rats following prolonged sex hormone administration

2-Methoxyestradiol: an endogenous antiangiogenic and antiproliferative drug candidate.

The role of steroid hormones in prostate carcinogenesis.

A liquid chromatography-mass spectrometry method for the simultaneous measurement of 15 urinary estrogens and estrogen metabolites: assay reproducibility and interindividual variability.

The physiological estrogen metabolite 2-methoxyestradiol reduces tumor growth and induces apoptosis in human solid tumors.

Prospective study of sex hormone levels and risk of prostate cancer.

Prostate cancer epidemiology.

Quantitative structure-activity relationship of various endogenous estrogen metabolites for human estrogen receptor alpha and beta subtypes: Insights into the structural determinants favoring a differential subtype binding.

The association of time of day and serum testosterone concentration in a large screening population.

Estrogen receptor beta in the prostate.

P304

507-516

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PROS.21262

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

71

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47158162

http://www.w3.org/2001/XMLSchema#string

P698

20886539

http://www.w3.org/2001/XMLSchema#string

P932

3037420

http://www.w3.org/2001/XMLSchema#string